Emamekhoo, H., Punekar, S. R., Gourdin, T. S., Levy, B. P., Villano, J. L., Villaruz, L. C., Lohrey, J., Spira, A. I., Cheung, K., Johansen, M., Madden, T., Maier, G., Shimoyama, S., Yamada, N., Subach, R. A., Wages, D. S., Langer, C. J. (2026). FF-10832 liposomal gemcitabine monotherapy or combination with pembrolizumab in patients with advanced non–small cell lung cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8560